The increase in carcinoembryonic antigen (CEA) of 37.1% and cytokeratin-19 fragments 21-1 (Cyfra 21.1) of 68.5% has sensitivity and diagnostic value in the NSCLC [18]. This evidence concerns the gene CEACAM5 and non-small cell lung carcinoma.